非酒精性脂肪肝疾病:病原和模型
Hanxiang Zhong1, Jiayong Dong1, Liye Zhu2
1Department of Liver Surgery and Organ Transplantation, Changzheng Hospital, Navy Medical University Shanghai, China.
American journal of translational research
|March 11, 2024
概括
非酒精性脂肪性肝病 (NAFLD) 涉及肝脏脂肪的积累和炎症,进展到严重的疾病. 动物模型对于理解NAFLD/NASH机制和开发新治疗方法至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 翻译研究是翻译研究.
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是一种普遍存在的肝脏疾病,其特点是过度的脂肪积累.
- NAFLD从简单的肥胖症发展为非酒精性肥胖肝炎 (NASH),肝硬化和肝细胞癌.
- 与肥胖,胰岛素抵抗和代谢综合征相关,NAFLD构成了重大的公共卫生挑战.
研究的目的:
- 总结目前对NAFLD和NASH病原体的理解.
- 讨论动物模型在NAFLD/NASH研究中的作用和类型.
- 突出需要改进治疗策略的需要.
主要方法:
- 关于NAFLD/NASH病变的文献综述.
- 在NAFLD/NASH研究中使用的常见动物模型的分析.
- 综合当前的治疗方法.
主要成果:
- 纳氏肺炎/纳氏肺炎的发病包括脂毒性,炎症,氧化应激和胰岛素抵抗.
- 动物模型对于研究分子机制和测试治疗方法至关重要.
- 现有的治疗方法包括改变生活方式,向炎症/抗氧化途径.
结论:
- 了解NAFLD/NASH病原体是不完整的,需要进一步的研究.
- 动物模型是推动NAFLD/NASH研究不可或缺的工具.
- 对NAFLD/NASH的有效治疗方法的开发正在进行中.
关键词:
动物模型动物模型组织病理学 组织病理学非酒精性脂肪肝疾病 (NAFLD) 是一种非酒精性脂肪肝疾病.非酒精性脂肪肝炎 (NASH) 是一种非酒精性脂肪肝炎.病变的发生和发病.治疗治疗治疗治疗治疗治疗更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.3K
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
1.9K
相关概念视频
Chronic Pancreatitis I: Introduction
89
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
89
Diseases of the Liver and Gallbladder
537
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
537
Overview of Lipid Metabolism
1.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.5K
Liver Physiology
546
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
546
